TWA
SRNE
TCI Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,990
| Closed | -$5K | – | 2701 |
|
|
2022
Q3 | $5K | Buy |
2,990
+393
| +15% | +$657 | ﹤0.01% | 1547 |
|
|
2022
Q2 | $5K | Buy |
2,597
+401
| +18% | +$772 | ﹤0.01% | 1568 |
|
|
2022
Q1 | $5K | Buy |
2,196
+1,039
| +90% | +$2.37K | ﹤0.01% | 1640 |
|
|
2021
Q4 | $5K | Buy |
1,157
+657
| +131% | +$2.84K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $4K | Sell |
500
-297
| -37% | -$2.38K | ﹤0.01% | 1850 |
|
|
2021
Q2 | $8K | Sell |
797
-9
| -1% | -$90 | ﹤0.01% | 1140 |
|
|
2021
Q1 | $7K | Buy |
806
+213
| +36% | +$1.85K | ﹤0.01% | 1084 |
|
|
2020
Q4 | $4K | Hold |
593
| – | – | ﹤0.01% | 1017 |
|
|
2020
Q3 | $7K | Hold |
593
| – | – | ﹤0.01% | 675 |
|
|
2020
Q2 | $4K | Buy |
+593
| New | +$4K | ﹤0.01% | 842 |
|
|
2019
Q4 | – | Sell |
-300
| Closed | -$1K | – | 1713 |
|
|
2019
Q3 | $1K | Sell |
300
-200
| -40% | -$667 | ﹤0.01% | 1428 |
|
|
2019
Q2 | $1K | Buy |
500
+200
| +67% | +$400 | ﹤0.01% | 1354 |
|
|
2019
Q1 | $1K | Buy |
300
+100
| +50% | +$333 | ﹤0.01% | 1344 |
|
|
2018
Q4 | $0 | Sell |
200
-100
| -33% | – | ﹤0.01% | 1716 |
|
|
2018
Q3 | $1K | Sell |
300
-200
| -40% | -$667 | ﹤0.01% | 1377 |
|
|
2018
Q2 | $4K | Buy |
500
+300
| +150% | +$2.4K | ﹤0.01% | 891 |
|
|
2018
Q1 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 1265 |
|